Biotherapy Services Limited
Non-Executive Chair
Biotherapy Services is a clinical-stage, pharmaceutical biotechnology company that's developing and delivering novel autologous therapies for complex and chronic wounds. The Company is currently under exclusivity and in due diligence with a prominent UK based private equity firm, raising a multi-million-pound growth funding round. They were seeking an experienced pharmaceutical/medicine biotech Chair who had knowledge of licensing and experience of leading a company through international expansion.
Through Nurole they appointed John Chiplin, PhD, who started his career as a research scientist at GSK and has since worked as CEO of Sydney based Arana Therapeutics (one of the largest publicly-quoted biotechs in Australia) as well as biotech Geneformatics as co-founder. He has significant experience in the life science and technology industries, from an operational, investment and international perspective, and is currently Managing Director of health-focused private equity firm Newstar Ventures.
I would never have found Biotherapy Services if it wasn’t for Nurole - it was off my radar, but when Nurole introduced me, I thought, ‘wow’... At first, [the Nurole application process] takes you through a script to answer certain questions - you’ve got to really think about them rather than the classical model of sending off your CV and it was... different, at first. But now I really enjoy the process: it makes you really think what do you want from this company and what does it want from you. Nurole is a leading-edge sophisticated platform and is going to have huge broad appeal.
John Chiplin
Managing Director, Newstar Ventures Ltd
Successful candidate
Nurole provides best-in-class hiring for forward-thinking boards. We blend the power and reach of technology with a very human understanding that every role, every organisation and every candidate is different. Contact us to discuss your next hire or find out more about becoming a member here.